Articles tagged with Health Insurance
Physician exit from traditional Medicare has increased over time, with exits remaining high even after the pandemic. The findings suggest that multiple factors contribute to physician departures, including the growing burden of new communication methods and demands for clinical documentation.
Proposed Medicaid reforms would have far-reaching consequences beyond federal budget savings, including negative health outcomes and economic losses. Rural and underserved communities are disproportionately affected by these policy changes.
A new study found that almost all Medicaid managed care plans (MCPs) cover at least one form of naloxone, with 94% covering generic injectables or 4-mg nasal sprays. However, certain restrictions and quantity limits may prevent people from accessing this life-saving drug.
A new study found that extending Medicaid coverage for 12 months after birth improved access to medical and behavioral health services. This expansion may help mitigate adverse outcomes, including chronic condition management.
The Families First Coronavirus Response Act led to a significant decrease in Medicaid health insurance loss. The study found that the Act reduced the risk of losing health insurance for individuals enrolled in the Medicaid program.
Eliminating the fee increased overall usage by 7.8 percentage points, particularly benefiting underserved populations, including non-English speakers and those from socioeconomically disadvantaged areas. Despite gains, some disparities persisted, highlighting the need for additional strategies to ensure equitable access.
Access to buprenorphine and naltrexone for opioid use disorder is affected by race and ethnicity, as well as insurance type. Targeted interventions, including culturally tailored care and expanded access points, are needed to address disparities and reduce inequities contributing to the overdose crisis.
Most opioid treatment programs still do not offer all three forms of medication-assisted treatment (MAT) as of 2023. Government-operated programs and those accepting Medicare are more likely to provide comprehensive MAT offerings.
A new study found significant variation in COPD prevalence and burden across states and insurance types, with West Virginia topping the list at 143 cases per 1,000 insured individuals and Utah ranking last at 44. The study also revealed high mortality rates among people with COPD in several states.
Most Medicare beneficiaries will likely see their drug costs go up due to Part D plans' shifting cost-sharing burden. The new $2,000 annual out-of-pocket limit won't reach most beneficiaries, leading to higher deductibles and coinsurance for many.
A cross-sectional study found substantial cost shifting in veterans' surgical care from Medicare Advantage to Veterans Health Administration among high-veteran Medicare Advantage plans. This shift underscores the urgent need for policy reforms to improve the efficiency of veterans' care, as suggested by the findings.
A state Medigap guaranteed issue protection was associated with a higher rate of switching to traditional Medicare among newly diagnosed cancer patients. This finding suggests that these regulations can facilitate a switch, especially for those who desire more flexibility in accessing care.
A new study found that problems with accessing high-quality care were a major driver for switching Medicare Advantage plans, not cost concerns. Dissatisfaction with medical care access was more common among those in poor health, and those who enrolled in MA plans with low star ratings were also more likely to switch.
A new study published in JAMA Internal Medicine reveals a concerning decline in self-reported mental health among mothers in the US between 2016 and 2023. The percentage of mothers reporting excellent mental health dropped sharply from 38% to 26%, while those rating their mental health as fair or poor increased by 63.6%.
A recent study on HealthCare.gov found that burdensome reenrollment policies led to a significant decrease in enrollment and an estimated quarter of a million Americans lost their Marketplace health insurance coverage in 2024. The researchers argue that increasing administrative burdens will lead to more coverage losses.
New research reveals that recreational cannabis legalization leads to significant reductions in prescription drug claims per enrollee, with annual savings of $34-$42 in small group insurance markets. However, the study found no similar effect in large group insurance markets.
A study found that veterans enrolled in Medicare Advantage (MA) plans use dental and vision services at a similar rate as those in traditional Medicare. MA plans spent only slightly more on these services, including emergency dental care. After accounting for private insurance coverage, the total spending on dental services was compara...
A recent study found that more beneficiaries were affected by insurer exits in the Part D marketplace under the IRA, which increased plan sponsor financial liability. The redesigned Part D marketplaces may lead to limited coverage options and less competitiveness.
A new University of Michigan study suggests that Medicaid unwinding may have disrupted the care of people receiving treatment for opioid addiction. Patients were less likely to continue filling buprenorphine prescriptions and more likely to pay with cash or private insurance in states with large versus small Medicaid enrollment drops.
This study found a decline in racial and ethnic disparities in receipt of ERBB2-targeted therapies among older Medicare beneficiaries with ERBB2-positive breast cancer. The narrowing of disparities may be attributed to changes in healthcare practices or policies over time.
A new poll by Michigan Medicine reveals that nearly two-thirds of Americans over 50 believe Medicare will cover their nursing home costs, despite it not currently paying for this type. Only half have taken key actions to prepare for long-term care needs. The poll also shows that 70% of people who survive to age 65 will need long-term c...
A new analysis predicts that reducing Medicaid access could lead to thousands of additional deaths among working-age Americans and disastrous financial burdens. The study found that eliminating the ACA provision expanding Medicaid access could drive millions to delay needed care.
The study estimates that expanded Medicare coverage for GLP-1RAs would increase access to these treatments and reduce obesity-related comorbidities. However, this would come with substantial costs over a decade, projected at $8 billion, highlighting the need for further price reductions and cost-saving strategies.
The percentage of publicly insured children receiving mental health or neurodevelopmental disorder diagnosis increased significantly between 2010 and 2019. Most diagnostic categories showed increases, emphasizing the importance of accessing appropriate services in safety net systems.
Families of children with disabilities experience higher adjusted odds for financial hardships due to inadequate health insurance policies. The study highlights the need for structured policies ensuring covered medical care without financial burden on families.
A study of over 300,000 adults found that those with diabetes are 25% more likely to lose their health insurance. Insurance instability is particularly concerning for those with complex needs, as many struggle to regain coverage after losing Medicaid or private insurance.
A study found that 76% of people aged 50+ have patient portal accounts, with 65% sending at least one message in the past year. However, 13% report paying co-pays or charges for these interactions, especially those with Medicaid or low incomes.
Tariffs on Canadian pharmaceuticals could significantly impact the US drug supply and costs, with an estimated $750 million added to production costs. The study found that $3 billion in US pharmaceuticals rely on Canadian manufacturing, highlighting the potential fragility of supply chains.
A new white paper finds that expanding access to anti-obesity medications can prevent or delay chronic disease by years, providing significant societal benefits. The study estimates a $10 trillion return on investment and 13% annual returns on investment for society.
Most older U.S. adults support Medicare covering weight management medications, particularly those with a BMI of 30 or greater. The survey also found that more than half of participants were interested in using these medications to manage their weight.
A large majority of older Americans believe health insurance – including Medicare – should cover anti-obesity medications. Nearly 37% of respondents met the criteria for overweight and 36% for obesity. Medicare currently covers a drug used for weight management but only in people with diabetes or a history of heart attack or stroke.
A study published in the International Journal of Manpower found that offering paid time off (PTO) significantly reduces the likelihood of employees quitting their jobs, with a greater reduction for men. PTO does not affect job satisfaction, which independently reduces turnover by 30-40%. Flexible scheduling also reduces turnover, but ...
A new study found that less than half of Medicaid managed care plans cover all four FDA-approved medications for treating alcohol use disorder. The majority of these plans covered naltrexone, while disulfiram and acamprosate were less commonly covered.
A study found that socioeconomically disadvantaged patients used emergency departments less for non-avoidable visits, despite an overall rebound in ED use by 2022. This trend reverses pre-pandemic increases in ED utilization among Medicaid and dual-eligible patients.
A new study by Boston University School of Public Health refutes claims that Medicaid expansion increases misuse of prescription opioids and benzodiazepines. Despite initial concerns, the study found no association between Medicaid expansion and non-prescribed opioid use among people who inject drugs.
A study found that starting stimulant medications via telehealth increases substance use disorder (SUD) risk, particularly among young adults aged 26-34. Ongoing screening and monitoring are crucial to mitigate this risk.
Differences in coinsurance rates associated with racial and ethnic disparities in out-of-pocket spending for maternity care. Changes to health plan benefit design could improve equity in maternal healthcare access and outcomes.
A cohort study found that telemedicine adoption was associated with modestly lower use of 7 out of 20 examined low-value tests, while having no effect on other tests. The results suggest potential benefits of telemedicine and mitigate concerns about increased spending.
A recent study found that Medicare decedents with advanced cancer often receive aggressive care at the end of life, despite a lack of support. The study highlights the need for improved quality of care and more comprehensive approaches to address this issue.
New research from USC reveals that Medicare Part D plans are increasingly tying patient costs to list prices, leading to substantially higher out-of-pocket costs for beneficiaries. The study found that the share of stand-alone plans using coinsurance for preferred branded drugs grew from 9.9% in 2020 to 71.9% in 2024.
Nearly 1 in 3 Americans face long drives and high costs for surgical care within an hour's drive. Rural adults are particularly affected, with 44% driving over an hour for operations.
A new poll by Michigan Medicine reveals that working past age 50 has positive impacts on physical health, mental wellbeing, and overall wellbeing. However, some experience negative effects, with 33% citing a negative effect on physical health and 29% saying it affects mental health.
The study found a notable drop in common ophthalmic procedures following the COVID-19 pandemic, especially laser peripheral iridotomy, which declined significantly in the hardest hit areas of the Northeast. Eye drug injections showed minimal changes during this time.
A recent study found that patients who left emergency departments before being medically advised had higher rates of readmission, mortality, and increased costs. The COVID-19 pandemic led to a 53.6% increase in such cases, primarily due to concerns about infection, long wait times, and dissatisfaction with care.
Research highlights three vulnerable populations: racial and ethnic minorities, financially insecure individuals, and those with chronic health conditions. Depression is a significant factor in social isolation among these groups.
A new study found a significant increase in firearm-related hospitalizations during the COVID-19 pandemic, with rates 34% higher than predicted pre-pandemic trends. The gap was largest for Black patients, children, and those covered by Medicaid, who experienced rates 44%, 46%, and 41% higher, respectively.
A significant increase in firearm-related hospital admissions was observed during the COVID-19 pandemic, with a 34% rise reported between 2020 and 2021. This surge had a disproportionate impact on vulnerable populations, including children, Medicaid patients, and Black individuals.
A new microdosing approach using low doses of buprenorphine has been tested on patients with opioid use disorder, but most found it ineffective. The study, which included 126 participants, showed that only 34% were able to work up to a full dose of buprenorphine.
Two new studies found that those who turned 65 after the ACA took effect had lower out-of-pocket health costs and fewer hospitalizations. However, dual-eligible individuals over 65 saw negative impacts from Medicaid 'unwinding,' with 12% losing coverage and many going without needed care due to cost.
A Michigan Medicine study suggests that higher out-of-pocket costs for initial cardiac rehabilitation sessions are a major barrier to participation. Patients who shared the cost of their first session attended more sessions than those who paid nothing, but still had lower odds of completing over 24 sessions.
A study by the American Academy of Neurology found that older adults with Medicare insurance wait an average of over a month to see a neurologist. Wait times varied depending on the condition, with people with multiple sclerosis and Parkinson's disease facing longer delays.
A recent study found that pregnant individuals with opioid use disorder enrolled in Medicaid are at a disproportionately high risk of severe maternal morbidity. Targeted interventions, such as early Medicaid enrollment and coverage continuity, may be necessary to reduce adverse outcomes in this group.
A longitudinal cohort study found that state cannabis legalization is associated with increased cannabis use disorder and poisoning diagnoses. Communities with increased access to cannabis may experience increased healthcare use and costs due to these rising diagnoses.
A new study found significant disparities in the use of obesity-management medications among different racial and ethnic groups. People of Asian, Black, and Hispanic descent were significantly less likely to use these medications compared to whites, even after adjusting for income, education, health insurance coverage, and clinical need.
The American Psychological Association's survey found that 34% of psychologists do not accept any form of health insurance, while 48% have participated in insurance networks. Insufficient reimbursement rates and administrative challenges are significant obstacles to psychologists working with insurance companies.
Researchers aim to identify 'ghost networks' in Medicare Advantage plans, where advertised providers differ from actual access options. The study will analyze nationwide data from 2017-2021 to pinpoint the extent of these disparities and their impact on patients.
A cross-sectional study found substantial projected annual savings from weight loss among U.S. adults with obesity, particularly for Medicare and employer-based insurance. The estimated reduction in healthcare spending is substantial, offering a potential benefit for individuals with obesity.
A RAND study found that hospitals increased the frequency of high-intensity care coding by 41% from 2011 to 2019, resulting in $14.6 billion in extra payments. This upcoding trend was largely driven by increases in heart failure and shock discharges.
A new study found that 5% of Canadian respondents skipped or reduced dosages due to cost-related issues. The research highlights the burden of prescription costs on vulnerable populations, including females, bisexual, and Indigenous individuals. The authors suggest that national pharmacare plans can help address these disparities.
A new UCLA study categorizes people with chronic liver disease into four unique risk groups based on barriers to outpatient care, increasing the likelihood of hospitalization. The study highlights the need for interventions aimed at reducing avoidable hospitalizations among the highest-risk individuals.